Skip to main content
. 2021 Jul 17;2021(7):CD011525. doi: 10.1002/14651858.CD011525.pub3

2.3. Analysis.

2.3

Comparison 2: Sensitivity analysis: IPTi with SP versus placebo or no IPTi, Outcome 3: All‐cause mortality